Pulmonary Hypertension at Penn (@pennmedph) 's Twitter Profile
Pulmonary Hypertension at Penn

@pennmedph

Follow for updates from the Penn Pulmonary Hypertension Team, a devoted group committed to bettering the lives of our patients.

ID: 1296435731720572928

linkhttps://www.pennmedicine.org/for-patients-and-visitors/find-a-program-or-service/heart-and-vascular/ calendar_today20-08-2020 13:16:01

264 Tweet

823 Followers

150 Following

Nicholas Kolaitis, MD MAS (@lungtxptmd) 's Twitter Profile Photo

Excited to share a UCSF Health and Cedars-Sinai collaboration recently published in CHEST. How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension - CHEST journal.chestnet.org/article/S0012-…

Pulmonary Hypertension at Penn (@pennmedph) 's Twitter Profile Photo

Huge congratulations to mentor extraordinaire, Dr. Nadine Al-Naamani, on receiving the ATS Pulmonary Circulation Assembly Mid-Career Research Achievement Award! A well-deserved honor for her impactful work and leadership in PH research. 👏🎉 #ATS2025 #WomenInMedicine ATS PC Assembly

Huge congratulations to mentor extraordinaire, Dr. Nadine Al-Naamani, on receiving the ATS Pulmonary Circulation Assembly Mid-Career Research Achievement Award!
A well-deserved honor for her impactful work and leadership in PH research. 👏🎉
#ATS2025 #WomenInMedicine <a href="/ATS_PC/">ATS PC Assembly</a>
ATS PC Assembly (@ats_pc) 's Twitter Profile Photo

open.spotify.com/episode/2tEgsB… A great listen on the ERJ podcast where Dr. Marius Hoeper discusses the safety and efficacy of sotatercept. Your next listen on your commute home🎧🚗🚶‍♀️🚶ERS publications

Pulmonary Hypertension at Penn (@pennmedph) 's Twitter Profile Photo

In a small series of PAH patients treated with sotatercept, withdrawal of selexipag was found to be safe, while discontinuation of parenteral treprostinil was feasible only in a subset of patients bit.ly/41UKcUi

In a small series of PAH patients treated with sotatercept, withdrawal of selexipag was found to be safe, while discontinuation of parenteral treprostinil was feasible only in a subset of patients
bit.ly/41UKcUi
Kurt Prins (@kurt_prins) 's Twitter Profile Photo

Nice editorial from Drs. Hemnes and Rischarge on Sasha Prisco, MD, PhD's latest paper highlighting areas for future research for the microbiome in RV inflammation and dysfunction. Thanks for sharing their thoughts! ahajournals.org/doi/10.1161/CI…